首页> 外文会议>International symposium on controlled release of bioactive materials;Consumer and diversified products conference >Influence of surface-modifying surfactants on the pharmacokinetic behavior of ~14C-poly (methylmethacrylate) nanoparticles in tumor models with different angiogenesis
【24h】

Influence of surface-modifying surfactants on the pharmacokinetic behavior of ~14C-poly (methylmethacrylate) nanoparticles in tumor models with different angiogenesis

机译:表面修饰表面活性剂对〜14C-聚甲基丙烯酸甲酯纳米颗粒在不同血管生成肿瘤模型中药代动力学行为的影响

获取原文

摘要

Macromolecular or colloidal drug carriers such as polymer drug conjugates, liposomes, and nanoparticles are rapidly gaining importance for the therapy of solid tumors~1,2 due to the EPR (enhanced permeability and retention) effect~3,4. The objective of the present study was to investigate the influence of the surface properties of vesicles on the transport of particles into different tumors. Polymethyl(2-~14C) methacrylate nanoparticles were used in combination with three surfactants, i.e. polysorbate 80, poloxamer 407, and poloxamine 908. Uncoated nanoparticles served as controls. Three tumor models were chosen, different in growth, angiogenesis, origin and localization.
机译:大分子或胶体药物载体,例如聚合物药物缀合物,脂质体和纳米颗粒,由于EPR(增强的渗透性和保留力)作用约3,4,在实体瘤的治疗中迅速变得重要,约1,2。本研究的目的是研究囊泡的表面性质对颗粒向不同肿瘤中转运的影响。聚(2-〜14C)甲基丙烯酸甲酯纳米颗粒与三种表面活性剂(即聚山梨酯80,泊洛沙姆407和泊洛沙明908)结合使用。未涂覆的纳米颗粒用作对照。选择了三种肿瘤模型,其生长,血管生成,起源和定位不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号